Skip to Content


In the US, Ceftibuten (ceftibuten systemic) is a member of the drug class third generation cephalosporins and is used to treat Bladder Infection, Bronchitis, Otitis Media, Pneumonia, Sinusitis, Strep Throat and Tonsillitis/Pharyngitis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

5-tia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-(2-amino-4-tiazolyl)-4-carboxy-1-oxo-2-butenyl]-amino]-8-oxo-, [6R-[6α,7β(Z)]]-

Foreign Names

  • Ceftibutenum (Latin)
  • Ceftibuten (German)
  • Ceftibutene (French)
  • Ceftibuteno (Spanish)

Generic Names

Brand Names

  • Caedax
    Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Portugal
  • Cedax
    Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, Slovakia; MSD, Switzerland; MSD, Sweden; MSD Italia, Italy; S.I.F.I., Serbia; Schering-Ploug Europe, Poland; Schering-Plough, Ecuador; Schering-Plough, Mexico; Schering-Plough, Romania; Schering-Plough, Slovenia; Schering-Plough, Turkey; Shionogi, United States; SIFI, Bulgaria; SIFI, Georgia
  • Isocef
    Recordati, Italy
  • Seftem
    Shionogi, Taiwan
  • Wincef
    Celtis, Turkey
  • Cedax
    Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Malaysia; Merck Sharp & Dohme, Singapore; MSD, Netherlands; MSD, Thailand; MSD Pharma, Hungary; Schering-Plough, Bangladesh; Schering-Plough, Venezuela
  • Cedax Baby (pediatric)
    MSD Pharma, Hungary
    MSD Chibropharm, Germany
  • KEIMAX forte
    MSD SHARP & DOHME, Germany
  • Procadax
    Fulford, India
  • Seftem
    Shionogi Seiyaku, Japan

International Drug Name Search


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.